{"id":46343,"date":"2018-03-09T11:14:44","date_gmt":"2018-03-09T15:44:44","guid":{"rendered":"https:\/\/piel-l.org\/blog\/?p=46343"},"modified":"2018-03-10T21:53:13","modified_gmt":"2018-03-11T02:23:13","slug":"la-aemps-ha-emitido-un-alerta-actualizando-las-recomendaciones-del-comite-para-la-evaluacion-de-riesgos-en-farmaco-vigilancia-europeo","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/46343","title":{"rendered":"La AEMPS ha emitido un alerta actualizando las recomendaciones del Comit\u00e9  Para La Evaluaci\u00f3n de Riesgos en Farmaco vigilancia Europeo"},"content":{"rendered":"<div>La Agencia Espa\u00f1ola de medicamentos y productos sanitarios (AEMPS) ha emitido un alerta con fecha 5 de marzo de 2018 actualizando las recomendaciones del Comit\u00e9 \u00a0Para La Evaluaci\u00f3n de Riesgos en Farmacovigilancia Europeo (PRAC) sobre<\/div>\n<div id=\"m_4698722153659886667AppleMailSignature\">\n<span style=\"color: #0000ff;\"><b><a style=\"color: #0000ff;\" href=\"https:\/\/seguridadmedicamento.sanidadmadrid.org\/home.aspx?accesoExterno=si&amp;tipo=noticia&amp;id=899\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=en&amp;q=https:\/\/seguridadmedicamento.sanidadmadrid.org\/home.aspx?accesoExterno%3Dsi%26tipo%3Dnoticia%26id%3D899&amp;source=gmail&amp;ust=1520814000647000&amp;usg=AFQjCNHlRT0O2ZpyKWNZX_uTApKhyUSA-Q\">RETINOIDES (ACITRETINA, ALITRENIOINA, ISOTRETINOINA): ACTUALIZACI\u00d3N DE LAS MEDIDAS PARA EVITAR LA EXPOSICI\u00d3N DURANTE EL EMBARAZO Y DE LAS ADVERTENCIAS SOBRE EFECTOS NEUROPSIQUI\u00c1TRICOS<\/a><\/b>.\u00a0<\/span><\/div>\n<blockquote><p>\nSe anexa link y documento en pdf<\/p><\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>Retinoides (acitretina, alitrenioina, isotretinoina): Actualizaci\u00f3n de las medidas para evitar la exposici\u00f3n durante el embarazo y de las advertencias sobre efectos neuropsiqui\u00e1tricos. <\/p>\n","protected":false},"author":4,"featured_media":46344,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-46343","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-farmacologia"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/46343","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=46343"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/46343\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media\/46344"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=46343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=46343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=46343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}